Objectıves: Non-neurogenic lower urinary tract dysfunction (NNLUTD) is rather com-mon in pediatric age group. In this study, we aimed to present the results of patients whom we treated by urotherapy.
Materıal and Methods: Twenty-one pati-ents applied to our clinic between January-Sep-tember 2013 with NNLUTD were enrolled into the study. Detailed history, Bladder Dysfuncti-on Symptom Questionnaire (BDSQ), Physical examination, urinalysis and urine culture, mic-turition diary, plasma urea and creatinine, lum-bosacral x-ray, uroflow-EMG and urinary ult-rasonography was used to evaluate the patients. All patients were managed by urotherapy and were called to re-evaluate after three months.
Results: Mean patient age was 10.47±3.08 (7-17). Six of those patients were male (28.6%) and fifteen was female (71.4%). Mean BDSQ were 19.19±4.28 and 5.57±2.94 before and af-ter treatment, respectively (p<0.05). With the re-evaluation of uroflow-EMG patterns, 16/21 (76.2%) patients were improved.
Conclusion: In conclusion, urotherapy is an efficient treatment method in patients with NNLUTD. With this treatment, both subjec-tive (BDSQ) and objective (uroflow-EMG) symptoms can be treated.
Key Words: Pediatric patient, Bladder Dysfunction, Urotherapy
Abstract
Objectıves: Non-neurogenic lower urinary tract dysfunction (NNLUTD) is rather com-mon in pediatric age group. In this study, we aimed to present the results of patients whom we treated by urotherapy.
Materıal and Methods: Twenty-one pati-ents applied to our clinic between January-Sep-tember 2013 with NNLUTD were enrolled into the study. Detailed history, Bladder Dysfuncti-on Symptom Questionnaire (BDSQ), Physical examination, urinalysis and urine culture, mic-turition diary, plasma urea and creatinine, lum-bosacral x-ray, uroflow-EMG and urinary ult-rasonography was used to evaluate the patients. All patients were managed by urotherapy and were called to re-evaluate after three months.
Results: Mean patient age was 10.47±3.08 (7-17). Six of those patients were male (28.6%) and fifteen was female (71.4%). Mean BDSQ were 19.19±4.28 and 5.57±2.94 before and af-ter treatment, respectively (p<0.05). With the re-evaluation of uroflow-EMG patterns, 16/21 (76.2%) patients were improved.
Conclusion: In conclusion, urotherapy is an efficient treatment method in patients with NNLUTD. With this treatment, both subjec-tive (BDSQ) and objective (uroflow-EMG) symptoms can be treated.
Key Words: Pediatric patient, Bladder Dysfunction, Urotherapy